Compare IVA & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IVA | CCB |
|---|---|---|
| Founded | 2011 | 1997 |
| Country | France | United States |
| Employees | 84 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 2018 |
| Metric | IVA | CCB |
|---|---|---|
| Price | $6.17 | $77.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $16.20 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 329.6K | 168.8K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.06 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $96.61 |
| Revenue Next Year | N/A | $22.66 |
| P/E Ratio | ★ N/A | $25.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.70 | $70.72 |
| 52 Week High | $7.98 | $120.05 |
| Indicator | IVA | CCB |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 37.51 |
| Support Level | $5.79 | $70.72 |
| Resistance Level | $6.48 | $118.03 |
| Average True Range (ATR) | 0.30 | 4.35 |
| MACD | -0.03 | 1.02 |
| Stochastic Oscillator | 28.69 | 50.15 |
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.